[1] |
Vogelmeier CF, Criner GJ, Martinez FJ , et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 Report. GOLD executive summary. Am J Respir Crit Care Med 2017; 195(5):557-82. doi: 10.1164/rccm.201701-0218PP.
doi: 10.1164/rccm.201701-0218PP
|
[2] |
Hanania NA, Sharma G, Sharafkhaneh A . COPD in the elderly patient. Semin Respir Crit Care Med 2010; 31(5):596-606. doi: 10.1055/s-0030-1265900.
doi: 10.1055/s-0030-1265900
pmid: 20941660
|
[3] |
Blanchette CM, Berry SR, Lane SJ . Advances in chronic obstructive pulmonary disease among older adults. Curr Opin Pulm Med 2011; 17(2):84-9. doi: 10.1097/MCP.0b013e32834316ff.
doi: 10.1097/MCP.0b013e32834316ff
pmid: 21178625
|
[4] |
Yuan YM. Aging and COPD. Chin J Clinician 2013; 7(2): 478-80. Chinese. doi: 10.3877/cma.j.issn.1674-0785.2013.02.008.
doi: 10.3877/cma.j.issn.1674-0785.2013.02.008
|
[5] |
Lou P, Zhu Y, Chen P . Prevalence and correlations with depression, anxiety and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med 2012; 12:53. doi: 10.1186/1471-2466-12-53.
doi: 10.1186/1471-2466-12-53
pmid: 22958576
|
[6] |
Cui GM, Zhu ZM , Xue YC. Related factors of the influence of depressive disorder on senior patients with COPD. Chin J practical Mervous Dis 2013; 16(20):33-5. Chinese. doi: 10.3969/j.issn.1673-5110.2013.20.018.
doi: 10.3969/j.issn.1673-5110.2013.20.018
|
[7] |
Russo E, Citraro R, Davoli A , et al. Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity. Neuropharmacology 2013; 64:371-9. doi: 10.1016/j.neuropharm.2012.06.039.
doi: 10.1016/j.neuropharm.2012.06.039
|
[8] |
Fernandez JW, Grizzell JA, Philpot RM , et al. Postpartum depression in rats: differences in swim test immobility, sucrose preference and nurturing behaviors. Behav Brain Res 2014; 272(4):75-82. doi: 10.1016/j.bbr.2014.06.041.
doi: 10.1016/j.bbr.2014.06.041
pmid: 24983658
|
[9] |
Lee B, Sur B, Cho SG , et al. Effect of Beta-Asarone on Impairment of Spatial Working Memory and Apoptosis in the Hippocampus of Rats Exposed to Chronic Corticosterone Administration. Biomol Ther (Seoul) 2015; 23(6):571-81. doi: 4062/biomolther.2015.027.
doi: 4062/biomolther.2015.027
pmid: 4624074
|
[10] |
Ellison D, White D, Farrar FC . Aging population. Nurs Clin North Am 2015; 50(1):185-213. doi: 10.1016/j.cnur.2014.10.014.
doi: 10.1016/j.cnur.2014.10.014
|
[11] |
de Voogd JN, Wempe JB, Koeter GH , et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest 2009; 135(3):619-25. doi: 10.1378/chest.08-0078.
doi: 10.1378/chest.08-0078
pmid: 19029432
|
[12] |
Chetta A, Foresi A, Marangio E , et al. Psychological implications of respiratory health and disease. Respiration 2005; 72(2):210-5. doi: 10.1159/000084056.
doi: 10.1159/000084056
pmid: 15824535
|
[13] |
Moisieieva NV, Burya LV, Kapustianskaya AA , et al. Comprehensive patterns of comorbidity: COPD and depression. Aspects of treatment. Wiad Lek 2018; 7(3 pt 1):588-91.
pmid: 29783230
|
[14] |
Bock K, Bendstrup E, Hilberg O , et al. Screening tools for evaluation of depression in Chronic Obstructive Pulmonary Disease (COPD). A systematic review. Eur Clin Respir 2017; 4(1):1332931. doi: 10.1080/20018525.2017.1332931.
doi: 10.1080/20018525.2017.1332931
pmid: 28649311
|
[15] |
Corlateanu A, Covantev S, Mathioudakis AG , et al. Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease. Respir Investig 2016; 54(6):387-96. doi: 10.1016 /j. resinv.2016.07.001.
doi: 10.1016 /j. resinv.2016.07.001
pmid: 27886849
|
[16] |
Lavrencic LM, Richardson C, Harrison SL , et al. Is there a link between cognitive reserve and cognitive function in the oldest-old? J Gerontol A Biol Sci Med 2018; 73(4):499-505. doi: 10.1093/gerona/glx140.
doi: 10.1093/gerona/glx140
pmid: 28977420
|
[17] |
van Beers M, Janssen DJA, Gosker HR , et al. Cognitive impairment in chronic obstructive pulmonary disease: disease burden, determinants and possible future interventions. Expert Rev Respir Med 2018; 12(12):1061-74. doi: 10.1080/17476348.2018.1533405.
doi: 10.1080/17476348.2018.1533405
|
[18] |
Aras YG, Tunc A, Güngen BD , et al. The effects of depression, anxiety and sleep disturbances on cognitive impairment in patients with chronic obstructive pulmonary disease. Cogn Neurodyn 2017; 11(6):565-71. doi: 10.1007/s11571-017-9449-x.
doi: 10.1007/s11571-017-9449-x
pmid: 29147148
|
[19] |
Burger C . Region-specific genetic alternations in the aging hippocampus: implications for cognitive aging. Front Aging Neurosci 2010; 2:140. doi: 10.3389/fnagi.2010.00140.
doi: 10.3389/fnagi.2010.00140
|
[20] |
Stockmeier CA, Mahajan GJ, Konick LC , et al. Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry 2004; 56(9):640-50. doi: 10.1016/j.biopsych.2004.08.022.
doi: 10.1016/j.biopsych.2004.08.022
|
[21] |
Zhu J, Mu X, Zeng J , et al. Ginsenoside Rg1 prevents cognitive impairment and hipppcamps senescence in a rat model of D-Galactose-induced Aging. PLoS One 2014; 9(6):e101291. doi: 10.1371/journal.pone.0101291.
doi: 10.1371/journal.pone.0101291
pmid: 24979747
|
[22] |
Martínez-Aguilar, NE,Vargas-Cama?o ME,Hernández-Pliego RR,et al. Immunopathology of chronic obstructive pulmonary disease. Rev Alerg Mex 2017; 64(3):327-46. doi: 10.29262/ram.v64i3.263.
doi: 10.29262/ram.v64i3.263
pmid: 29046030
|
[23] |
Diniz BS, Mendes-Silva AP, Silva LB , et al. Oxidative stress markers imbalance in late-life depression. J Psychiatr Res 2018; 102:29-33. doi: 10.1016/j.jpsychires.2018.02.023.
doi: 10.1016/j.jpsychires.2018.02.023
pmid: 29574402
|